SALUS, Ljubljana, d. d. (LJSE:SALR)

Market Cap	410.96M
Revenue (ttm)	664.50M
Net Income (ttm)	14.37M
Shares Out	8.22M
EPS (ttm)	1.75
PE Ratio	28.65
Forward PE	n/a
Dividend	1.03 (2.05%)
Ex-Dividend Date	n/a

Volume	435
Average Volume	296
Open	49.60
Previous Close	50.00
Day's Range	49.60 - 50.00
52-Week Range	25.64 - 58.00
Beta	0.46
RSI	52.86
Earnings Date	Nov 4, 2025

About SALUS, Ljubljana, d. d.

SALUS, Ljubljana, d. d. engages in the distribution, promotion, sales services, and value-added services for medicinal products or medical devices in Slovenia and internationally. The company offers commercial partnerships to pharmaceutical, biotechnology, consumer healthcare, and medical device companies; and medicinal products, medical devices, sanitary products, dietary supplements, cosmetics, pharmaceutical packaging, and other products to pharmacies, hospitals, community health centers, residential homes for the elderly, veterinary institu...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1969
• Employees: 618
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: SALR

Financial Performance

In 2024, SALUS, Ljubljana, d. d.'s revenue was 648.83 million, an increase of 8.24% compared to the previous year's 599.44 million. Earnings were 12.85 million, an increase of 25.14%.